RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • Drugs expensive under plans sold on health exchange, survey finds

    Drugs expensive under plans sold on health exchange, survey finds
    The Affordable Care Act is not so affordable for many Marylanders, according to a new survey. The landmark law that was supposed to make insurance available to hundreds of thousands of people without coverage is costing Marylanders so much more in...
  • Hogan's budget includes some cuts, some status quo for economic development programs

    Hogan's budget includes some cuts, some status quo for economic development programs
    Advocates for programs spending state dollars on stem cell research or investment in technology companies were nervous about what Gov. Larry Hogan's budget would hold for them, given warnings of "strong medicine" to cure fiscal woes. But after Hogan's...
  • AbbVie's new hepatitis C treatment gets approval in EU

    AbbVie's new hepatitis C treatment gets approval in EU
    Drugmaker AbbVie Inc. said Monday that its new, all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries. The company said the European Commission granted marketing authorization for the combination...
  • Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016

    Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
    A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys. Privately held Marathon Pharmaceuticals...
  • Gilead counters AbbVie with exclusive hepatitis C drug deal of its own

     Gilead counters AbbVie with exclusive hepatitis C drug deal of its own
    CVS Health announced Monday that it plans to make Gilead Sciences' hepatitis C drugs the exclusive option for most of its consumers starting Wednesday. The announcement comes two weeks after Express Scripts, the nation's largest manager of prescription...
  • AbbVie will rely on arthritis staple, new HCV drug in 2015

    AbbVie will rely on arthritis staple, new HCV drug in 2015
    North Chicago-based AbbVie issued a strong outlook for 2015 on Thursday after the markets closed. The biopharmaceutical company that was spun off from Abbott Laboratories expects earnings per share between $3.99 and $4.19 in 2015. The company said...
  • Express Scripts, CVS Health Dropping Coverage For Many Brand-Name Drugs: Why?

    Express Scripts, which handles prescription-drug benefits for millions of people nationwide, is dropping coverage for 66 brand-name drugs in January in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....
  • Walgreens Boots Alliance unveils new logo

    Walgreens Boots Alliance unveils new logo
    Walgreens Boots Alliance unveiled a new logo Friday, a sphere meant to look like a globe that is a corporate departure from the red W that has been a fixture at its U.S. drugstores for years. The logo for the Walgreens stores is not changing, the...
  • Company denies rat poison in pills linked to India sterilization deaths

    Company denies rat poison in pills linked to India sterilization deaths
    The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison. Preliminary tests...
  • AbbVie lowers price of hepatitis C drug to win deal with Express Scripts

    AbbVie lowers price of hepatitis C drug to win deal with Express Scripts
    AbbVie has substantially cut the price of its newly approved hepatitis C drug to win an exclusive deal with Express Scripts, the nation's largest manager of prescription drug benefits, the companies said Monday. Starting Jan. 1, Express Scripts will stop...
  • Gilead shares plunge after Express Scripts spurns its $1,000 hepatitis C pill

    Gilead shares plunge after Express Scripts spurns its $1,000 hepatitis C pill
    Gilead Sciences Inc., already under fire for the high costs of its hepatitis C drugs, took another hit Monday when the nation's largest manager of pharmacy benefits struck an exclusive deal with a rival drugmaker. Express Scripts Holding Co. said Monday...